Enova International grants Chartier 2,366 options
The award vests in one-third increments only if service continues through each date; the tandem SAR has a limited post-change-in-control exercise window.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Enova International, Inc. Chief Strategy Officer Kirk Chartier received a grant of 2,366 non-qualified stock options with a limited stock appreciation right on November 3, 2026. The options have an exercise price of $186.21 per share and expire November 3, 2033. They vest in substantially equal one-third increments on November 3, 2027, November 3, 2028 and November 3, 2029, provided he remains an employee through each vesting date. The tandem SAR may be exercised only from the first day after a defined Change in Control through the 30th day after it, and payment is available only if a qualifying Offer is made.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Non-Qualified Stock Option (right to buy) with limited SAR F1, F2, F3 | 2,366 | $0.00 | $0.00 |
Footnotes (3)
- F1. The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made.
- F2. The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer.
- F3. The options shall vest in substantially equal one-third increments on each of the following dates as long as grantee serves as an employee of Issuer or an affiliate thereof through the applicable vesting date: November 3, 2027, November 3, 2028 and November 3, 2029.
Key Figures
Key Terms
Non-Qualified Stock Option financial
limited stock appreciation right financial
Change in Control technical
Offer financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How many options did Enova's chief strategy officer receive, and at what exercise price?
When do Kirk Chartier's ENVA options vest?
What are the terms of the limited SAR attached to Kirk Chartier's ENVA option grant?
AI-generated analysis. How Rhea-AI works. Not financial advice.